Emerging roles of exosomes in cancer invasion and metastasis

키워드

참고문헌 (72)

1. Raposo G, "Extracellular vesicles:exosomes, microvesicles, and friends", J Cell Biol, 200, pp.373~383 (2013)
2. EL Andaloussi S, "Extracellular vesicles: biology, emerging therapeutic opportunities", Nat Rev Drug Discov, 12, pp.347~357 (2013)
3. Johnstone RM, "Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles(exosomes)", J Biol Chem, 262, pp.9412~9420 (1987)
4. Vlassov AV, "Exosomes : Current knowledge of their composition, biological functions, , diagnostic, therapeutic potentials", Biochim Biophys Acta, 1820, pp.940~948 (2012)
5. Kharaziha P, "Tumor cell-derived exosomes: A message in a bottle", Biochim Biophys Acta, 1826, pp.103~111 (2012)
6. Valadi H, "Exosome-mediated transfer of mRNAs, microRNAs is a novel mechanism of genetic exchange between cells", Nat Cell Biol, 9, pp.654~659 (2007)
7. Milane L, "Exosome mediated communication within the tumor microenvironment", J Control Release, 219, pp.278~294 (2015)
8. Théry C, "Exosomes : composition, biogenesis, function", Nat Rev Immunol, 2, pp.569~579 (2002)
9. Robbins PD, "Regulation of immune responses by extracellular vesicles", Nat Rev Immunol, 14, pp.195~208 (2014)
10. Hanson PI, "Multivesicular body morphogenesis", Annu Rev Cell Dev Biol, 28, pp.337~362 (2012)
11. Stuffers S, "Multivesicular Endosome Biogenesis in the Absence of ESCRTs", Traffic, 10, pp.925~937 (2009)
12. Hemler ME, "Specific tetraspanin functions", J Cell Biol, 155, pp.1103~1107 (2001)
13. Edidin M, "Shrinking patches, slippery rafts:scales of domains in the plasma membrane", Trends Cell Biol, 11, pp.492~496 (2001)
14. Pant S, "The multifaceted exosome: biogenesis, role in normal, aberrant cellular function, and frontiers for pharmacological, biomarker opportunities", Biochem Pharmacol, 83, pp.1484~1494 (2012)
15. King HW, "Hypoxic enhancement of exosome release by breast cancer cells", BMC Cancer, 12, pp.421~ (2012)
16. Nazarenko I, "Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation", Cancer Res, 70, pp.1668~1678 (2010)
17. Hoshino A, "Tumour exosome integrins determine organotropic metastasis", Nature, 28, pp.15756~ (2015)
18. Blanchard N, "TCR activation of human T cells induces the production of exosomes bearing the TCR", CD3, J Immunol Baltim Md, pp.2002, 168[DOI]
19. Montecalvo A, "Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes", Blood, 119, pp.756~766 (2012)
20. Kahlert C, "Exosomes in tumor microenvironment influence cancer progression, metastasis", J Mol Med, 91, pp.431~437 (2013)
21. Théry C, "Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles", J Immunol Baltim Md, 166, pp.7309~7318 (2001)
22. Al-Nedawi K, "Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells", Nat Cell Biol, 10, pp.619~624 (2008)
23. Demory Beckler M, "Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS", Mol Cell Proteomics, 12, pp.343~355 (2013)
24. Corcoran C, "Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes, potential for resistance transfer via exosomes", PloS One, 7, pp.e50999~ (2012)
25. Peinado H, "Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET", Nat Med, 18, pp.883~891 (2012)
26. Hood JL, "Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis", Cancer Res, 71, pp.3792~3801 (2011)
27. Sidhu SS, "The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions", Oncogene, 23, pp.956~963 (2004)
28. Luga V, "Tumor-stroma interaction:Revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis", Cancer Res, 73, pp.6843~6847 (2013)
29. Huber V, "Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape", Gastroenterology, 128, pp.1796~1804 (2005)
30. Klibi J, "Blood diffusion, Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells", Blood, 113, pp.1957~1966 (2009)
31. Théry C, "Membrane vesicles as conveyors of immune responses", Nat Rev Immunol, 9, pp.581~593 (2009)
32. Wolfers J, "Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming", Nat Med, 7, pp.297~303 (2001)
33. Andre F, "Malignant effusions, immunogenic tumour-derived exosomes", Lancet, 360, pp.295~305 (2002)
34. Andreola G, "Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles", J Exp Med, 195, pp.1303~1316 (2002)
35. Xiang X, "Induction of myeloid-derived suppressor cells by tumor exosomes", Int J Cancer, 124, pp.2621~2633 (2009)
36. Wieckowski EU, "Tumor-derived microvesicles promote regulatory T cell expansion, induce apoptosis in tumor-reactive activated CD8+ T lymphocytes", J Immunol, 183, pp.3720~3730 (2009)
37. Ohshima K, "Let-7microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line", PloS One, 5, pp.e13247~ (2010)
38. Anastasiadou E, "Malicious exosomes", Science, 346, pp.1459~1460 (2014)
39. Madhavan B, "Combined evaluation of a panel of protein, miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity, specificity", Int J Cancer, 136, pp.2616~2627 (2015)
40. Taylor DD, "MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer", Gynecol Oncol, 110, pp.13~21 (2008)
41. Ogata-Kawata H, "Circulating Exosomal microRNAs as Biomarkers of Colon Cancer", PLoS One, 9, pp.e92921~ (2014)
42. Yang M, "Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells", Mol Cancer, 10, pp.117~ (2011)
43. Wang M, "Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers, a mechanism for gastric cancer", Br J Cancer, 110, pp.1199~1210 (2014)
44. Fabbri M, "MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response", Proc Natl Acad Sci U S A, 109, pp.E2110~E2116 (2012)
45. Umezu T, "Leukemia cell to endothelial cell communication via exosomal miRNAs", Oncogene, 32, pp.2747~2755 (2013)
46. Zhou W, "Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis", Cancer Cell, 25, pp.501~515 (2014)
47. Record M, "Exosomes as new vesicular lipid transporters involved in cell-cell communication, various pathophysiologies", Biochim Biophys Acta, 184, pp.108~120 (2014)
48. Sahu R, "Microautophagy of cytosolic proteins by late endosomes", Dev Cell, 20, pp.131~139 (2011)
49. Dikic I, "ALIX-ing phospholipids with endosome biogenesis", BioEssays, 26, pp.604~607 (2004)
50. Matsuo H, "Role of LBPA, Alix in Multivesicular Liposome Formation, Endosome Organization", Science, 303, pp.531~534 (2004)
51. Laulagnier K, "PLD2 is enriched on exosomes, its activity is correlated to the release of exosomes", FEBS Lett, 572, pp.11~14 (2004)
52. Trajkovic K, "Ceramide triggers budding of exosome vesicles into multivesicular endosomes", Science, 319, pp.1244~1247 (2008)
53. Strauss K, "Exosome Secretion Ameliorates Lysosomal Storage of Cholesterol in Niemann-Pick Type C Disease", J Biol Chem, 285, pp.26279~26288 (2010)
54. Ikonen E, "Roles of lipid rafts in membrane transport", Curr Opin Cell Biol, 13, pp.470~477 (2001)
55. Tan SS, "Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane", J Extracell Vesicles, 2, pp.22614~ (2013)
56. Llorente A, "Molecular lipidomics of exosomes released by PC-3 prostate cancer cells", Biochim Biophys Acta, 1831, pp.1302~1309 (2013)
57. Lydic TA, "Rapid, comprehensive"shotgun"lipidome profiling of colorectal cancer cell derived exosomes", Methods, 4, pp.014~ (2015)
58. Wang D, "Eicosanoids, cancer", Nat Rev Cancer, 10, pp.181~193 (2010)
59. Esser J, "Exosomes from human macrophages, dendritic cells contain enzymes for leukotriene biosynthesis, promote granulocyte migration", J Allergy Clin Immunol, 126, pp.1032~1040 (2010)
60. Aung T, "Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3", Proc Natl Acad Sci U S A, 108, pp.15336~15341 (2011)
61. Skog J, "Glioblastoma microvesicles transport RNA, proteins that promote tumour growth, provide diagnostic biomarkers", Nat Cell Biol, 10, pp.1470~1476 (2008)
62. Silva J, "Analysis of exosome release, its prognostic value in human colorectal cancer", Genes Chromosomes Cancer, 51, pp.409~418 (2012)
63. He M, "Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins, RNAs", Carcinogenesis, 36, pp.1008~1018 (2015)
64. Rodríguez M, "Exosomes enriched in stemness", metastatic-related mRNAS promote oncogenic potential in breast cancer, 2015, pp.6, 40575~40587
65. Merino AM, "Therapeutic potential of extracellular vesicles", Front Immunol, 5, pp.658~ (2014)
66. Savina A, "Exosome Release Is Regulated by a Calcium-dependent Mechanism in K562 Cells", J Biol Chem, 278, pp.20083~20090 (2003)
67. Chalmin F, "Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse, human myeloid-derived suppressor cells", J Clin Invest, 120, pp.457~471 (2010)
68. Ohno S, "Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells", Mol Ther, 21, pp.185~191 (2013)
69. Sun D, "A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes", Mol Ther, 18, pp.1606~1614 (2010)
70. Escudier B, "Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial", J Transl Med, 3, pp.10~ (2005)
71. Pitt JM, "Dendritic cell-derived exosomes as immunotherapies in the fight against cancer", J Immunol, 193, pp.1006~1011 (2014)
72. Tian Y, "A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy", Biomaterials, 35, pp.2383~2390 (2014)

관련 논문AI추천